tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Sionna Therapeutics sees cash runway into 2028
PremiumThe FlySionna Therapeutics sees cash runway into 2028
3M ago
Sionna Therapeutics reports Q4 EPS ($3.38) vs. ($3.93) last year
Premium
The Fly
Sionna Therapeutics reports Q4 EPS ($3.38) vs. ($3.93) last year
5M ago
Sionna Therapeutics sees cash runway into 2028
Premium
The Fly
Sionna Therapeutics sees cash runway into 2028
5M ago
Sionna Therapeutics initiated with a Buy at Stifel
PremiumThe FlySionna Therapeutics initiated with a Buy at Stifel
6M ago
Sionna Therapeutics initiated with a Buy at Guggenheim
Premium
The Fly
Sionna Therapeutics initiated with a Buy at Guggenheim
6M ago
Sionna Therapeutics: Promising NBD1 Stabilizers Poised to Challenge Vertex in the $11 Billion CF Market
Premium
Ratings
Sionna Therapeutics: Promising NBD1 Stabilizers Poised to Challenge Vertex in the $11 Billion CF Market
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100